ACTIVEFINE Share Price Performance
৳8.50
-5.50 (-39.29%)
Price ৳8.50
Share Price৳8.50
ACTIVEFINE Community Narratives
There are no narratives available yet.
Recent ACTIVEFINE News & Updates
No updates
Active Fine Chemicals Limited Key Details
Last Reported Earnings
Mar 31, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Active Fine Chemicals Limited Competitors
About ACTIVEFINE
- Founded
- 2004
- Employees
- n/a
- CEO
- WebsiteView website
Active Fine Chemicals Limited produces and sells bulk drugs/active pharmaceutical ingredients (APIs) and various laboratory reagents in Bangladesh. The company’s APIs include azithromycin dihydrate, erythromycin ethyl succinate, and erythromycin stearate for macrolide-antibiotics; esomeprazole magnesium trihydrates and pellets for anti-ulcerant; fluconazoles for anti-fungal; atorvastatin and rosuvastatin calcium for lipid-lowering; cetirizine and fexofenadine hydrochlorides, desloratadines, and ebastine for anti-histamine; and ciprofloxacin hydrochloride for anti-bacterial therapeutics. It also offers cefixime trihydrates and cefuroxime axetil for cephalosporin-antibiotics; metformin hydrochloride, sitagliptin phosphate monohydrate, vildagliptin, linagliptin, gliclizide, and glimepiride for anti-diabetic; pregabalin for anti-epileptic; paracetamol for analgesic and antipyrotic; losartan potassium and amlodipine besylate for anti-hypertensive; calcium orotate for use in calcium-supplement; sofosbuvir for anti-hepatitis-C; etoricoxib and ketorolac tromethamine for NSAID; and ticagrelor and amlodipine besylate for anti-platelet therapeutic areas, as well as solvents and powder reagents. Active Fine Chemicals Limited was incorporated in 2004 and is based in Dhaka, Bangladesh.
Bangladeshi Market Performance
- 7 Days: 0.01%
- 3 Months: 9.1%
- 1 Year: 1.5%
- Year to Date: 1.6%
The Real Estate sector gained 7.8% while the market remained flat over the last week. As for the longer term, the market has also been flat over the past year. Earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading